Playback speed
10 seconds
ASH 2022 Patient Reports Outcomes & Health-Related Quality of Life From the OUTREACH Study: Lisocabtagene Maraleucel in Patients With R/R LBCL Treated as Outpatients/Inpatients in the Community/Non-University Setting
By
ASH 2022 Conference Coverage
FEATURING
Yuliya Linhares
By
ASH 2022 Conference Coverage
FEATURING
Yuliya Linhares
33 views
April 3, 2023
Login to view comments.
Click here to Login